These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36524109)

  • 21. What is antibody-mediated pure red cell aplasia (PRCA)?
    Casadevall N
    Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv3-8. PubMed ID: 15827056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
    Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
    Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid resolution of EPO-induced pure red cell aplasia after a course of immunoadsorption therapy using protein A columns.
    Westerlund P; Kurkus J; Segelmark M
    Am J Kidney Dis; 2005 Jun; 45(6):e97-9. PubMed ID: 15957124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful reintroduction of a different erythropoiesis-stimulating agent after pure red cell aplasia: relapse after successful therapy with prednisone.
    Andrade J; Taylor PA; Love JM; Levin A
    Nephrol Dial Transplant; 2005 Nov; 20(11):2548-51. PubMed ID: 16046510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pure red-cell aplasia caused by the antibody to recombinant erythropoietin, epoetin-beta, in a Japanese patient with chronic renal failure.
    Shinohara K; Mitani N; Miyazaki M; Sakuragi S; Matsuda K; Ogawara S; Saito T; Kaneoka H; Ooji T
    Am J Hematol; 2005 Jan; 78(1):15-20. PubMed ID: 15609276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin.
    Casadevall N
    Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii37-41. PubMed ID: 14608000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful Treatment of Antibody-mediated Pure Red Cell Aplasia Induced by Continuous Erythropoietin Receptor Activator with Prednisolone.
    Okahashi N; Kubo M; Hoshino E; Uchihara M; Amano I; Tanaka H
    Intern Med; 2022 Jul; 61(14):2209-2213. PubMed ID: 34980800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study.
    Verhelst D; Rossert J; Casadevall N; Krüger A; Eckardt KU; Macdougall IC
    Lancet; 2004 May; 363(9423):1768-71. PubMed ID: 15172775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.
    Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P;
    J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients.
    Rahbar M; Chitsazian Z; Abdoli F; Moeini Taba SM; Akbari H
    J Nephropathol; 2017 Jan; 6(1):25-29. PubMed ID: 28042550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients.
    Kharagjitsingh AV; Korevaar JC; Vandenbroucke JP; Boeschoten EW; Krediet RT; Daha MR; Dekker FW;
    Kidney Int; 2005 Sep; 68(3):1215-22. PubMed ID: 16105053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-epoetin-antibody-induced anemia in a child with chronic renal failure.
    Jöbsis JJ; Fijnvandraat K; Stapel SO; Bouts AH
    Pediatr Nephrol; 2010 May; 25(5):993-4. PubMed ID: 20165889
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: multiple options.
    Rossert J; Macdougall I; Casadevall N
    Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv23-26. PubMed ID: 15827054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery of pure red-cell aplasia secondary to antierythropoietin antibodies after cessation of recombinant human erythropoietin.
    Panchapakesan U; Austin SK; Shafransky A; Lawrence JA; Savdie E
    Intern Med J; 2003; 33(9-10):468-71. PubMed ID: 14511202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin.
    Martelli M; Ponchio L; Beguin Y; Meloni G; Mandelli F; Cazzola M
    Haematologica; 1994; 79(5):456-9. PubMed ID: 7843633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to recombinant human erythropoietin causing pure red cell aplasia.
    Prabhakar SS; Muhlfelder T
    Clin Nephrol; 1997 May; 47(5):331-5. PubMed ID: 9181281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of acute pulmonary embolism induced by recombinant erythropoietin during treatment of pure red cell aplasia associated with thymoma: A case report.
    Cui X; Wan Z; Ma Z; Liu L; Yang Y
    Medicine (Baltimore); 2019 Mar; 98(10):e14789. PubMed ID: 30855492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple immunosuppressive therapy can accelerate the recovery of antibody-mediated pure red cell aplasia and allow successful concurrent resumption of erythropoietin.
    Ruangkanchanasetr P; Srichaikul T; Supaporn T
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S92-5. PubMed ID: 22934452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic mechanisms of EPO-associated pure red cell aplasia.
    Schellekens H
    Best Pract Res Clin Haematol; 2005; 18(3):473-80. PubMed ID: 15792922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of neutralizing antibodies to erythropoietin by inhibition of rHuEPO-stimulated EGR1 gene expression in the UT-7/EPO cell line.
    Ferguson J; Bird C; Wadhwa M; Burns C
    J Immunol Methods; 2013 Jan; 387(1-2):191-8. PubMed ID: 23142458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.